HEMERUS Medical
Hemerus Leukosep Filtration System
HEMERUS Medical - Innovative Technologies

LEUKOSEP® Filtration System

The LEUKOSEP® HRC-600-C Leukocyte Reduction Filtration System for Red Blood Cells is a single use device which reduces leukocytes from a single unit of CPD/AS-1 Red Blood Cells prior to long term storage. The fluid pathway is sterile and non-pyrogenic. The LEUKOSEP® System includes a leukocyte reduction filter, red blood cell storage container, associated tubing, clamps and connector.

System Advantages
  • Easy, one-step process: Simply Hang It — and Walk Away™
  • No operator intervention required
  • No vents, caps or check valves
  • No burping or stripping
  • No clamps to attend to during the filtration process
  • Auto-draining system
  • Self-priming filter
  • True closed system

Clinical Testing

The LEUKOSEP® System met new stringent regulatory criteria for in vitro and in vivo clinical testing:

A one-sided 95% lower confidence limit for the true proportion of units with a:

  • Filtration recovery of red blood cell mass of at least 85% is greater than 95%.
  • Residual leukocyte content of less than 5 x 106 per unit is greater than 95%.
  • Hemolysis at end of storage of less than 1% is greater than 95%.

 

Mean 24-hour post transfusion, in vivo red cell recovery at end of storage of at least 75% with standard deviation of at most 9%, and the lower limit of a one-sided 95% confidence interval for the population proportion of successes is 70% or greater. Success is defined as a subject that has at least 75% in vivo 24-hour recovery.

In vivo Clinical Results

LEUKOSEP® System In vivo 24-hour Radiolabeled Red Blood Cell Recovery Study (Double Label 51Cr/99mTc Method)

During clinical studies conducted at three U.S. sites, 24 out of 24 subjects (24/24) demonstrated in vivo 24 hour red blood cell recovery at end of storage of ≥75%.


Indications for Use:

The LEUKOSEP® HRC-600-C Leukocyte Reduction Filtration System for Red Blood Cells is indicated for pre-storage leukoreduction of a single unit of CPD/AS-1 Red Blood Cells.
  • AS-1 Red Blood Cells processed and filtered at room temperature within 8 hours after blood collection, then stored as AS-1 Red Blood Cells, Leukocytes Reduced at 1-6 °C within 8 hours.
  • Whole blood stored at 1-6 °C within 8 hours after blood collection. Red Blood Cells prepared and AS-1 added within 48 hours of collection. Leukocyte Reduction filtration initiated no later than Day 3 after collection.

Filtered Red Blood Cells may be stored for a period appropriate for the anticoagulant and preservative solutions used.


Caution: Federal Law (US) restricts this device to sale by or on the order of a physician or properly licensed practitioner. Refer to Instructions for Use for indications, contraindications, warnings and precautions.

© 2008 HEMERUS MEDICAL, LLC. HEMERUS, LEUKOSEP, LEUKOWEB and LEUP are Trademarks of HEMERUS Medical, LLC.